Dongxu Shu is the founder of Bowang Pharmaceutical. Latest round: Series A. Based in Shanghai, China.
Dongxu Shu is the Co-founder and Chief Executive Officer of Argo Biopharma, a clinical-stage biotechnology company focused on developing next-generation siRNA therapeutics for chronic disease management. Before co-founding Argo Biopharma, Dr. Shu worked as a senior scientist at Arrowhead Pharmaceuticals, where his work contributed to the development of extrahepatic delivery platforms used in clinical studies. He holds a Ph.D. in chemistry from the University of Wisconsin-Madison and a B.S. from Peking University.
Full founder directory · Investor directory · Company funding database · Fundraising library